These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7505056)

  • 41. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas.
    Kearsley JH; Leonard JH; Walsh MD; Wright GR
    Pathology; 1991 Jul; 23(3):189-94. PubMed ID: 1685773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
    Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
    Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of immunohistochemical detection of VEGF in prostate carcinoma.
    Kamath A; Helie M; Bifulco CB; Li WW; Concato J; Jain D
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):227-32. PubMed ID: 19098681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidermal growth factor receptor expression by northern analysis and immunohistochemistry in benign and malignant prostatic tumours.
    Harper ME; Goddard L; Glynne-Jones E; Peeling WB; Griffiths K
    Eur J Cancer; 1995; 31A(9):1492-7. PubMed ID: 7577078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers.
    Moe RE; Moe KS; Porter P; Gown AM; Ellis G; Tapper D
    Am J Surg; 1991 May; 161(5):580-3. PubMed ID: 1674411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
    Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of protooncogene c-erbB-2 in benign and malignant human prostate.
    Watanabe M; Nakada T; Yuta H
    Int Urol Nephrol; 1999; 31(1):61-73. PubMed ID: 10408305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.
    Kapitanović S; Radosević S; Kapitanović M; Andelinović S; Ferencić Z; Tavassoli M; Primorać D; Sonicki Z; Spaventi S; Pavelic K; Spaventi R
    Gastroenterology; 1997 Apr; 112(4):1103-13. PubMed ID: 9097992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
    Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
    Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
    Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
    Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).
    Hiesiger EM; Hayes RL; Pierz DM; Budzilovich GN
    J Neurooncol; 1993 May; 16(2):93-104. PubMed ID: 7507162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
    Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
    Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.
    Cohen DW; Simak R; Fair WR; Melamed J; Scher HI; Cordon-Cardo C
    J Urol; 1994 Dec; 152(6 Pt 1):2120-4. PubMed ID: 7525998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
    Cohen JA; Yachnis AT; Arai M; Davis JG; Scherer SS
    J Neurosci Res; 1992 Apr; 31(4):622-34. PubMed ID: 1374476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures.
    Jones EG; Harper ME
    Prostate; 1992; 20(2):133-49. PubMed ID: 1372429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
    Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
    Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide- induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells.
    Mann AM; Asamoto M; Masui T; Macatee T; Eklund SH; Cohen SM
    Cancer Lett; 1994 Aug; 84(1):7-13. PubMed ID: 7915640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.